中国自动化腹膜透析专家共识在杭发布,加快推进APD治疗在中国临床应用

2020-11-27 中国医师协会肾脏内科医师分会 国家肾脏病质控中心 中国医师协会肾脏内科医师分会 国家肾脏病质控中心

11月26日,由中国医师协会肾脏内科医师分会和国家肾脏病质控中心联合编撰的《自动化腹膜透析中国专家共识》(以下简称《共识》)在杭州正式发布。

11月26日,由中国医师协会肾脏内科医师分会和国家肾脏病质控中心联合编撰的《自动化腹膜透析中国专家共识》(以下简称《共识》)在杭州正式发布。这是我国首个针对自动化腹膜透析制定的专家共识,旨在提升自动化腹膜透析(APD)临床治疗的规范化水平和治疗质量,并借助基于互联网的APD远程智能化管理,优化医疗资源配置,助力分级诊疗建设,在推动中国肾脏病防治事业发展的同时,助力“健康中国2030”。

 
2020年11月26日,《自动化腹膜透析治疗中国专家共识》正式发布。
 
我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足

由于中国幅员辽阔,各地区从事血液净化的医疗单位的条件也不同,加之经济欠发达地区还存在交通限制,因此,大量ESRD患者的透析治疗需求还得不到满足。根据流行病学调查显示,我国ESRD患者总数约100-200万人,但截至2019年底,全国血液净化病例信息登记系统(CNRDS)登记的在透患者(含血液透析和腹膜透析)仅73.5万人,还未达到理想的治疗率。
 
同时,接受透析治疗的患者也对自身生活质量和回归社会的能力提出了更高的要求。中国工程院院士、中国中西医结合学会会长、中国医师协会肾脏内科医师分会会长陈香美院士指出,“只有综合考虑透析患者的身体健康、心理健康和社会关系,才能切实提高他们治疗的获得感。”
 
自动化腹膜透析亟需普及,全面提升患者更高获益

APD机自20世纪80年代问世后不断改良升级,其使用方便、容易调整透析剂量,不影响患者日常活动等优点正在被越来越多患者接受,APD治疗的适用范围也一直在拓展。
 
根据2000年国际腹膜透析协会、2005年欧洲腹膜透析佳实践指南推荐,APD的优势还在于,适用于高转运状态超滤衰竭的PD患者,并能有效降低其死亡及技术风险;清除小分子溶质能力强,透析效能提高;人工换液频率减少,感染风险降低;透析剂量易调整,人工成本减少等。
 
基于互联网的APD远程智能化管理,全面升级APD治疗

近年来,随着具有互联网功能的APD机和远程患者监测(RPM)系统的出现,APD治疗进入远程智能化时代。 
 
对于患者而言,腹膜透析远程监测平台兼具实用性和易用性,能够定期进行健康教育,远程获得医生的操作指导,可以达到降低腹膜炎、精细化容量管理,降低再住院率,改善预后的目的。
 
对于医护而言,利用远程监测实施及时、全程和全周期管理,不仅可以减少相关并发症的发生,提高治疗的依从性,减少患者门诊随访频率,而且还可以降低医疗费用,节约医疗资源。
 
此外,在疫情防控方面,居家的自动化腹膜透析体现出特别的优势:避免免疫力相对低下的透析患者频繁往返医院,并在相对隔离的空间进行透析治疗。
 
首个APD中国专家共识发布,加快我国APD的临床应用普及助力健康中国2030

目前,全球范围内APD的使用仍以发达国家居多,在欧美国家APD的应用已非常广泛,美国、加拿大、澳大利亚、英国等国家 APD使用率超过50%,而由于我国APD使用起步较晚,且发展不均衡,根据2019年CNRDS报告显示,中国的APD使用率仅为1.9%。
 
因此,陈香美院士呼吁:“希望通过本《共识》,团结全国肾内科的同道们,凝聚集体智慧和力量,共同推动APD治疗的知晓率及应用率,提高我国ESRD患者的治疗率,改善透析患者的生活质量,让我国从血液净化的大国,发展成血液净化的强国。”她表示,APD在今后的逐渐普及,将有望提升我国突发公共卫生事件的应急保障能力,推进卫生健康治理体系和治理能力现代化,加快实现健康中国,数字中国和制造强国,助力实现我国社会主义现代化两个一百年的远景目标。
 
参考文献

1,Rosner M H, Lew S Q, Conway P, et al. Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT[J]. Clin J Am Soc Nephrol,2017,12(11):1900-1909.
2,Wallace E L, Rosner M H, Alscher M D, et al. Remote Patient Management for Home Dialysis Patients[J]. Kidney Int Rep, 2017,2(6):1009-1017.
3,Bieber S D, Weiner D E. Telehealth and Home Dialysis: A New Option for Patients in the United States[J]. Clin J Am Soc Nephrol, 2018,13(8):1288-1290.
4,全国血液净化病例信息登记系统(CNRDS)调查数据
5,Li P K, Chow K M, Van de Luijtgaarden M W, et al. Changes in the worldwide epidemiology of peritoneal dialysis[J]. Nat Rev Nephrol, 2017,13(2):90-103.
6,Canadian Institute for Health Information. Canadian organ replacement register annual report:Treatment of end-stage organ failure in Canada,2001 to 2010 [DB / OL]. Ottawa, Ontario, Canada:CIHI, 2011 [2015-04-08]. http: / /www. cihi. ca/CIHIext-portal/internet/EN/Home/home/cihi000001.[R].
7,Sun C Y, Lee C C, Lin Y Y, et al. In younger dialysis patients, automated peritoneal dialysis is associated with better long-term patient and technique survival than is continuous ambulatory peritoneal dialysis[J]. Perit Dial Int, 2011,31(3):301-307.
8,《2018 年国家医疗服务与质量安全报告》:肾脏病专业医疗质量报告部分[Z].

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-08-20 nahsey

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2021-09-14 zhs3882
  5. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-12-25 uplimit

    不错

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-29 xuyong530
  8. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-28 王君256

    学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1009610, encodeId=9d821009610a2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/b7a64c53cc944fed9f929b23bad22004/7f2fd5fb135d454e823fcf64fa76bd8f.jpg, createdBy=b07a5542322, createdName=nahsey, createdTime=Fri Aug 20 07:45:31 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845832, encodeId=6d14184583266, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Apr 22 18:14:40 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1835881, encodeId=09ba1835881dc, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Aug 11 10:14:40 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952836, encodeId=2e081952836b2, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Sep 14 05:14:40 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910980, encodeId=164b9109802d, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce11611506, createdName=uplimit, createdTime=Fri Dec 25 22:37:18 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361890, encodeId=256b136189038, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623854, encodeId=975f16238547e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Nov 29 08:14:40 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903014, encodeId=685f90301459, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI8sjzdiaaUibRibZj10WicE8liaqdGPcTGFibicsGctovac81liaibOlhP1Ap08CslOqDLlLpjoUlypOs22mg/132, createdBy=07f02549050, createdName=王君256, createdTime=Sat Nov 28 13:04:42 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902891, encodeId=6951902891d3, content=我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Fri Nov 27 17:50:30 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 Jessie Zhang

    我国终末期肾脏病患者人数约100到200万人,诸多临床需求未被满足

    0